Our findings showed a significant downregulation of DAGAR in pulmonary arteries from COPD patients when compared to non-smoker patients (NS) (Figure 2B), similar in relative change to that observed after TNFα treatment on SMCs. Here, DAGARR is linked to chronic obstructive pulmonary disease.